European Academy of Allergy and Clinical Immunology(EAACI) Annual Congress 2025, Glasgow, İngiltere, 13 - 16 Haziran 2025, (Yayınlanmadı)
From Itch to Emergency: Eczema Herpeticum Threat in Atopic Dermatitis Patients
Background:
Atopic dermatitis (AD) is a common chronic, recurrent, itchy, and inflammatory
skin disease in children. Secondary infections can occur in AD patients due to
disrupted skin barriers. Eczema herpeticum (EH) frequently develops in AD
patients through the dissemination of the herpes simplex virus. In our case
series, we present the characteristics of EH-diagnosed patients with underlying
AD, providing an overview of its diagnosis and treatment.
Methods:
The study included 8 cases diagnosed with EH, followed at Istanbul University
Istanbul Faculty of Medicine, Division of Pediatric Immunology and Allergy,
between January 2018 and January 2025. Demographic and clinical features, as
well as follow-up and treatment details, were retrospectively evaluated. Consents
were obtained from the patients' guardians.
Results:
All cases were diagnosed with AD, including 3 females and 5 males, with a mean
age of 6 years (± 4.2 SDS). Assessment of atopic
dermatitis severity using the SCORAD index revealed a mean score of (75.9± 0,50
SDS), categorizing all cases as severe AD. Vesiculopapular and pustular lesions
with hemorrhagic crusts compatible with eczema herpeticum findings were
localized to the face in 2 cases, involved the extremities, face, and trunk in 4
cases, were confined to the neck in 1 case, and affected both the face and
extremities in 1 case. A history of herpes labialis was detected in only 2
families. Clinical diagnoses were also confirmed in 2 cases by HSV-1 DNA. All
cases received acyclovir treatment, none of them had keratoconjunctivitis. All
cases had early-onset AD begining in infancy and topical calcineurin inhibitor had
been used in one patient. Four cases experienced recurrent episodes, and one
case presented with encephalopathy during hospitalization. Seven cases showed
no complications. Genetic testing was recommended for all patients.
Conclusion:
Although eczema herpeticum affects approximately 3% of children with AD, EH can
be life-threatening if untreated or complicated, necessitating urgent
management. It should be considered in the differential diagnosis in acute
flares of AD.